Loading clinical trials...
Loading clinical trials...
The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Elgan Pharma Ltd.
NCT02623400 · Premature Birth of Newborn
NCT02452580 · Premature Birth of Newborn
NCT07499843 · Risky Baby, Premature Birth of Newborn, and more
NCT02508571 · Premature Birth of Newborn, Intervention Studies
NCT02523222 · Hypoglycemia, Infant, Small for Gestational Age, and more
Vidant Medical Center
Greenville, North Carolina
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Medical University of South Carolina
Charleston, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions